These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Apolipoprotein E genotypes in patients investigated for dementia]. Johannsen P; Jakobsen JK; Jørgensen AL Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872 [TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of apolipoprotein E in Alzheimer's disease. Frisoni GB; Bianchetti A; Govoni S; Trabucchi M Ann Neurol; 1996 Oct; 40(4):688-9. PubMed ID: 8871593 [No Abstract] [Full Text] [Related]
6. The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease. Galasko D West J Med; 1998 Apr; 168(4):264-5. PubMed ID: 9584668 [No Abstract] [Full Text] [Related]
7. Apolipoprotein E and Alzheimer's disease. Strittmatter WJ; Roses AD Annu Rev Neurosci; 1996; 19():53-77. PubMed ID: 8833436 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Roses AD Ann Neurol; 1995 Jul; 38(1):6-14. PubMed ID: 7611727 [No Abstract] [Full Text] [Related]
9. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Levy-Lahad E; Lahad A; Wijsman EM; Bird TD; Schellenberg GD Ann Neurol; 1995 Oct; 38(4):678-80. PubMed ID: 7574468 [TBL] [Abstract][Full Text] [Related]
10. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease. Hardy J Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162 [TBL] [Abstract][Full Text] [Related]
13. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset]. Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154 [TBL] [Abstract][Full Text] [Related]
15. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. van Duijn CM; de Knijff P; Wehnert A; De Voecht J; Bronzova JB; Havekes LM; Hofman A; Van Broeckhoven C Ann Neurol; 1995 May; 37(5):605-10. PubMed ID: 7755355 [TBL] [Abstract][Full Text] [Related]
16. [Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations]. Okochi M; Takeda M Nihon Rinsho; 2004 Jan; 62 Suppl():86-9. PubMed ID: 15011326 [No Abstract] [Full Text] [Related]
17. Apolipoprotein E and its association with Alzheimer's disease. Perls TT J Insur Med; 1996; 28(2):114-8. PubMed ID: 10172880 [No Abstract] [Full Text] [Related]
18. [Molecular genetics of apolipoprotein E and its receptors, implications for genetic risk factors of Alzheimer's disease]. Okuizumi K; Tsuji S Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1460-4. PubMed ID: 8741397 [No Abstract] [Full Text] [Related]
19. Detection of preclinical Alzheimer's disease. Skoog I N Engl J Med; 2000 Aug; 343(7):502-3. PubMed ID: 10944568 [No Abstract] [Full Text] [Related]
20. No increased risk of the apolipoprotein E epsilon2 allele with early-onset Alzheimer's disease. Corder EH; Roses AD Ann Neurol; 1996 Mar; 39(3):414-6. PubMed ID: 8602768 [No Abstract] [Full Text] [Related] [Next] [New Search]